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Introduction: A reproducible method is crucial in establishing cough sensitivity. Although 
reproducibility of the tidal-breath dose-response (TB-DR) method using capsaicin has been 
validated; the same method using citric acid is uninvestigated. This study determined the 
variability across multiple cough reflex tests (CRT) of suppressed cough thresholds in healthy 
individuals.  
Materials & Methods: Sixteen healthy volunteers underwent five CRTs (inter-test interval 
of at least 30 mins) within a single day. The TB-DR method was used to administer 
progressively increasing 0.1 mol/L increments of citric acid, ranging from 0.1-1.6 mol/L. Up 
to three 15-second trials of each concentration (45-second inter-trials interval) were 
administered via facemask. Placebo trials of saline were randomly interspersed. The 
suppressed cough threshold was defined as the lowest concentration producing two 
consecutive coughs on 2/3 trials. Data were analysed using a linear mixed effects model. The 
95% prediction interval for within-participant variability was derived from the model using a 
bootstrapping method.  
Results: The fixed effect results revealed that the mean SCT at baseline test across 
participants (model intercept) was 0.29 mol/L, 95% bootstrapped CI [0.12, 0.45]. The effect 
of test on SCT was 0.003 mol/L, 95% bootstrapped CI [-0.02, 0.03]. For the random effects, 
the variability due to participants at baseline SCT was 0.33 mol/L, 95% bootstrapped CI 
[0.21, 0.45]. The variability of the CRT effect between participants was 0.04 mol/L, 95% 
bootstrapped CI  [0.02,  0.06] while the variability for the residuals (within participant 
variability) was 0.08 mol/L, 95% bootstrapped CI  [0.06,  0.09]. The 95% prediction interval 
for the residuals (variability within a participant) was [-0.14mol/L,  0.16 mol/L]. 
Conclusions: This study defined the variability of citric acid CRT using the TB-DR method. 




the high percentage of variability for baseline SCT between participants suggests caution in 
establishing normative thresholds. The fairly consistent within-participant measures suggest 
CRT may be useful for repeated measures in tracking change as treatment effect within an 
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Cerebrovascular accident (CVA), or stroke, was ranked as the third most common 
cause of death in New Zealand in 2012, after cancer and ischaemic heart disease, and 
approximately 9,000 new stroke cases are reported annually (Ministry of Health [MOH], 
2015). The prognosis of stroke depends largely on the severity and site of lesion. Swallowing 
impairment, also termed dysphagia, is a frequently documented consequence of stroke. The 
prevalence of post-stroke dysphagia (detected using clinical and/ or instrumental 
assessments) ranges from 40-81% worldwide (Martino et al., 2005). About 44% of these 
patients will present with persisting swallowing disorders and episodes of aspiration (food or 
fluid entering the lungs) after the acute phase of the illness (Marik & Kaplan, 2003). In a 
large-scale study (N = 14,293) investigating stroke outcomes, it was reported that pneumonia 
increases the risk of 1-month mortality by up to three times, further indicating that efforts are 
required to reduce and prevent pneumonia among stroke patients (Katzan, Cebul, Husak, 













 “Silent penetration” was first used by Linden and Siebens (1983) to describe patients 
who presented with laryngeal penetration on videofluoroscopic swallowing study (VFSS) 
while clinical sign such as cough was not observed. As research in identifying aspiration in 
dysphagic patients continues to expand, contemporary terminology identifies “silent 
aspiration” is the entry of saliva, liquid or food below the glottis without triggering a cough 
reflex or other overt signs such as choking, gagging, “wet-hoarse” voice, throat clearing 
response (Garon, Engle, & Ormiston, 1996; Garon, Sierzant, & Ormiston, 2009; Horner, 
Massey, Riski, Lathrop, & Chase, 1988; Linden & Siebens, 1983; McCullough, Wertz, & 
Rosenbek, 2001; Ramsey, Smithard, & Kalra, 2005; Sakai et al., 2016). 
 
2.1 Prevalence of SA 
An early study conducted by Horner and colleagues (1988) evaluated the clinical 
correlations and outcomes of aspiration following stroke through oral motor-sensory 
examination and VFSS in 47 patients. Patients were evaluated at mean 2.9 months post-
stroke (ranging from one to 29 months). Subjective clinical signs such as coughing, gagging, 
choking, swallowing reflex, and vocal quality were documented through clinical 
examination. On VFSS, oral preparation, presence or absence of swallowing and coughing 
reflexes, as well as pharyngeal motility, were observed. Their findings revealed that just over 
half of the stroke patients (51.1%) aspirated on VFSS. Of these, 45.8% aspirated with an 
overt cough reflex, whereas 54.2% presented with silent aspiration. These findings 
highlighted the need for sensitive bedside clinical examinations in detecting SA among those 
patients. Subsequently, more studies were done to evaluate SA among dysphagic stroke 
patients. Daniels and colleagues (1998) conducted a study to evaluate the occurrence and 




aspirated, only 33% of them demonstrated overt signs of aspiration and 67% of them 
aspirated silently.  
The lack of standardised protocol in detecting SA (e.g: cough reflex test [CRT] 
methodology, VFSS protocol and reproducibility of CRT results) across settings, reveals a 
range of prevalence from 17.6% to 46.9% of stroke patients (Guillén-Solà et al., 2015; 
Maeshima et al., 2007; Sato et al., 2012; Vilardell et al., 2017; Wakasugi et al., 2008, 2014). 
These findings suggest that SA is a crucial problem in managing patients while highlighting 
the need for a standardised and reproducible protocol for detecting SA.  
 
2.2 Correlation between SA and aspiration pneumonia    
While the high prevalence of SA among dysphagic stroke patients has been 
documented, Sekizawa and colleagues (1990) attempted to evaluate the correlation between 
the presence of cough reflex and occurrence of aspiration pneumonia in five elderly patients 
with neurological disorders. They recruited 10 controls who had neurological disorders and 
five patients who presented with aspiration pneumonia. Using the tidal-breath dose-response 
(TB-DR) method, all participants were administered citric acid aerosols in incremental 
concentrations from 0.03% to 36% and the lowest dose which triggered five consecutive 
coughs was recorded as an individual’s corresponding cough threshold. In terms of 
methodology, details regarding the number of trials for each concentration, nebulisation time 
and output rate were not reported. All participants in the control group coughed at some point 
with a mean cough threshold of 1.06 (SE 0.18) logmg/ml. In contrast, all patients with 
aspiration pneumonia presented with an absent cough reflex across all concentrations. They 
concluded that the absence or attenuation of cough reflex could be one of the contributing 




provoked further investigations into the association between cough reflex and aspiration 
pneumonia.  
A more recent cohort study using capsaicin cough test discovered that reduced cough 
reflex might weaken protection against aspiration pneumonia (Niimi et al., 2003). Seven 
patients with a history of recurrent pneumonia were recruited and compared to a healthy 
control group. Patients with recurrent pneumonia were reported to have consistently higher 
cough thresholds compared to controls. The absence of cough reflex has been shown in 
multiple studies to highly correlate with aspiration pneumonia in patients with swallowing 
disorders (Marik & Kaplan, 2003; Nakajoh et al., 2000; Nakazawa, Sekizawa, Ujiie, Sasaki, 
& Takishima, 1993; Pontoppidan & Beecher, 1960) as well as mortality risk in acute 
ischemic stroke patients (Aviv et al., 1997).  
 
2.3 Diagnosis of SA 
2.3.1 Instrumental assessment (VFSS & FEES) 
To date, the ‘gold standard’ instrumental assessment methods for evaluating cough and 
swallowing  are the fiberoptic endoscopic evaluation of swallowing (FEES) and VFSS, 
despite the lack of standardisation across practitioners and documentation of acceptable 
reliability (Lee, Kim, Seo, & Kang, 2014; O’Donoghue & Bagnall, 1999; Ramsey, Smithard, 
& Kalra, 2003). During the VFSS, a range of textures and volumes are presented to a patient 
to ensure the most representative study of patient’s swallowing skill. The lateral plane is 
known for best detecting aspiration and providing optimum visualisation of the 
oropharyngeal function of swallowing (Miles, Moore, et al., 2013). By providing high-quality 
fluoroscopic imaging, the VFSS allows clinicians to identify anatomical or physiological 
dysfunction. Additionally, evaluation of compensatory approaches and therapeutic strategies 




The FEES  procedure was first introduced in 1988 by Langmore and colleagues. This 
procedure involves insertion of a flexible scope transnasally to a patient’s pharynx. The high-
resolution technology allows real-time viewing of anatomical structures and recording of 
task-specific movements such as at rest, speaking, breath-holding, pre- and post-swallow 
aspiration. Similar to VFSS, FEES enables clinicians to assess an individual patient’s 
swallowing skill and detect aspiration, as well as presence or absence of a cough.  
Despite their advantage in detecting overt and silent aspiration, VFSS and FEES often 
require special training and skilled staff to perform the procedure. Additionally, there are 
significant costs related to procurement and maintenance of the FEES and VFSS equipment 
apart from the radiation exposure during the VFSS procedure. As with other invasive 
procedures, during a FEES procedure, insertion of the flexible laryngoscope through an 
individual's nasal passage and into the pharynx often leads to discomfort and may interrupt 
swallowing in some patients (Adachi, Umezaki, & Kikuchi, 2017). Though, Leder et al. 
(1997) through a double-blind randomised clinical trial revealed that FEES procedure is well 
tolerated even without the used of topical anaesthetic, vasoconstrictor or lubricant to the nasal 
mucosa prior to the procedure. Having addressed all the pros and cons of the instrumental 
procedures, alternative screening assessments are required to help to increase the sensitivity 









Citric Acid Cough Challenge	
Irritant-induced cough challenge was first explored over 60 years ago (Bickerman, 
Barach, & Drimmer, 1954; Bickerman, German, Cohen, & Itkin, 1957) to assess the cough-
suppressing effect of pulmonary pharmaceutical drugs. Over the years, it has been used as an 
objective assessment tool of cough reflex sensitivity in humans (Wright, Jackson, Thompson, 
& Morice, 2010). In clinical practice, irritant-induced cough plays two major roles: (1) 
disease diagnosis and (2) progression tracking for disease or treatment (Fuller, 2002). Several 
cough stimulants – primarily capsaicin (Brandimore, Troche, Huber, & Hegland, 2015; 
Dicpinigaitis, Chang, Dicpinigaitis, & Negassa, 2016; Millqvist & Bende, 2001; Wise, 
Breslin, & Dalton, 2012, 2014), distilled water (Fontana et al., 1999; Lavorini et al., 2007; 
Lowry, 1994), tartaric acid (Stephens, Addington, & Widdicombe, 2003) and citric acid 
(Chou, Scarupa, Mori, & Canning, 2008; Ebihara et al., 2011; Gui et al., 2010; Kallesen, 
Psirides, & Huckabee, 2016; Kashiwazaki et al., 2013; Katsumata, Sekizawa, Ebihara, & 
Sasaki, 1995; Rostami-Hodjegan, Abdul-Manap, Wright, Tucker, & Morice, 2001) – have 
been used in these studies, with tartaric, citric acid and capsaicin most commonly 
documented (Chung, 1996; Morice et al., 2007).  
Recently, irritant-induced inhalation cough challenge using tartaric or citric acid has 
been introduced as an adjunct to clinical assessment of swallowing in dysphagic patients and 
is commonly known as the CRT. Numerous studies have demonstrated that CRT can be a 
stand-alone or an adjunct screening tool for predicting risk of SA in patients with dysphagia 
or elderly people (Addington, Stephens, Gilliland, & Rodriguez, 1999; Fujiwara et al., 2017; 
Kallesen et al., 2016; Lee et al., 2014; Miles, Moore, et al., 2013; Nakajoh et al., 2000; Oba et 
al., 2017; Sakai et al., 2016; Sato et al., 2012; Wakasugi et al., 2014, 2008; Yamanda et al., 
2008). However, most of these studies did not address the reproducibility of CRT. The test-




of the importance of the test, the standardisation of CRT methodology guidelines have been 
established by the European Respiratory Society (ERS) task force to improve the consistency 
of test administration across research laboratories. 
 
3.1 Dosing methods  
Selection of stimulant concentration has been addressed in several ways. Usually, the 
serial dilution method is used to produce a range of concentrations. The serial dilution 
method involves stepwise dilution of a stimulant in solution. Generally, the dilution factor at 
each step is constant, resulting in a geometric progression of the concentration in a 
logarithmic fashion. Across cough literature, the most frequently used dilution factors are 
half-logarithmic and two-fold. The half-logarithmic dilution (100.5-fold as the constant 
dilution factor) gives rise to a range of concentrations from 0.001 to 1 mol/L (e.g. 0.001, 
0.003, 0.01, 0.03, 0.1, 0.3 and 1 mol/L) regardless of the type cough stimulants used.  
On the other hand, the two-fold dilution gives rise to a range of doubling concentrations 
of stimulant used. Nonetheless, the range of concentration varies across laboratories as do the 
type of cough stimulants involved. Examples of commonly used range of concentrations 
using two-fold dilution: 0.98-1000 µmol/L (Dicpinigaitis, 2003a), 0.49-4000 µmol/L 
(Dicpinigaitis et al., 2016; Nejla, Fujimura, & Kamio, 2000), 0.61-1250 µmol/L ([Varechova 
et al., 2007] – a study done in 27 children), 0.016-50 µmol/L (Midgren, Hansson, Karlsson, 
Simonsson, & Persson, 1992) for capsaicin; 7.8-1000 mmol/L (Wright et al., 2010), 0.028-
1870 mmol/L (Watando et al., 2004), 0.01-3.3 mmol/L (Barros, Zammattio, & Rees, 1990) 
and 0.025-0.85 mol/L (Pounsford & Saunders, 1985) for citric acid. In addition, the 0.1 mol/L 
and 0.2 mol/L dilution factors are extensively used by one laboratory in New Zealand (Miles, 




The lack of standardisation across laboratories, given that ERS guidelines also overlooked 
this issue, hinders the interpretation and translation of research findings into clinical works.  
 
3.2 Administering methodologies  
At present, the two widely used administration methodologies are single-dose (SD) and 
dose-response (DR) methods (Morice et al., 2007; Morice, Higgins, & Yeo, 1992; Morice, 
Kastelik, & Thompson, 2001; Pounsford & Saunders, 1985; Wong & Morice, 1999). The SD 
method involves the use of only one concentration of the cough stimulant. This method is 
time efficient, has a lower tendency for tachyphylaxis (a rapid improvement of tolerance in 
response to an active substance after a few initial doses; [Nichols, 2010]) and is commonly 
used in clinical practice. The DR method can be conducted either through single-breath (SB; 
also known as vital capacity method) or tidal-breath (TB). 
The SB method usually requires participants to exhale to residual volume and then 
inhale the cough stimulant to their total lung capacity which usually takes place within 1-1.2 
seconds (Pounsford & Saunders, 1985). In contrast, the TB method generally demands 
participants to breathe normally during the presentation of increasing concentrations of cough 
stimulant over a fixed duration, which is usually 15-60 seconds (Morice et al., 2007). The 
testing protocol would usually require the participant to breathe through their mouth either 
via a mouthpiece or facemask. Placebo trials of 0.9% sodium chloride (NaCl) are typically 
interspersed randomly between increasing concentrations throughout the testing procedure to 
increase participant blinding. Usually, the number of coughs in 15 seconds immediately after 
each trial will be recorded. The lowest concentration to elicit two (C2) or five (C5) 
consecutive coughs will be treated as an individual’s cough threshold (Morice et al., 2007, 




response suggests a poor reproducibility of the C5 response; C2, therefore, is a preferred and 
extensively used outcome measure across laboratories (Morice et al., 2007).   
 
3.3 Sensitivity and specificity of CRT  
Sensitivity and specificity of CRT as a bedside screening tool in predicting aspiration 
pneumonia have been explored and are reported to range from 17-92% and 67-100%, 
respectively, across the literature (Addington et al., 1999; Guillén-Solà et al., 2015; Lee et al., 
2014; Miles, Moore, et al., 2013; Oba et al., 2017; Sato et al., 2012; Wakasugi et al., 2008, 
2014). The lack of standardised methodology used in conducting CRT and incomplete details 
reported across research laboratories have led to this wide range of sensitivity and specificity.  
Miles and colleagues (2013b) using the TB-DR method, conducted a study to evaluate 
the sensitivity and specificity of citric acid CRT. They evaluated the validation of a simple, 
quick and portable citric acid CRT against instrumental tests in identifying aspiration in 181 
patients. A total of 80 patients underwent VFSS and the remaining 101 patients received a 
FEES. All patients completed a CRT either before or after the instrumental test in a random 
manner. A portable nebuliser with an 8L prefixed free-flow output and restricted flow rate of 
6.6 L/min was used to administer citric acid aerosol. The citric acid concentration of 0.4, 0.6 
and 0.8 mol/L were administered in an ascending manner (1-minute interval). Each 
concentration was presented over 15 seconds and up to three doses per concentration. Placebo 
trials were interspersed between incremental concentrations to increase participant blinding. 
All patients were instructed to breathe comfortably and cough whenever they felt the need to 
cough. Production of cough over the 15 seconds delivery period was recorded. A positive 
result was considered if a C2 response was generated on the presentation of citric acid. The 
lowest concentration with a positive result on 2/3 of the trials was treated as the patient’s 




detecting aspiration within patients who aspirated were maximised at 0.6 mol/L – 71%, 71% 
respectively. On the other hand, the optimal sensitivity and specificity for CRT were 85% and 
71% at 0.4 mol/L, when compared against FEES.  
The authors concluded that the low citric acid concentrations (0.4-0.6 mol/L) are more 
sensitive for predicting SA than high concentration (0.8 mol/L). They also suggested that in 
identifying aspiration, CRT is superior to other components of bedside examinations such as 
assessment of jaw strength, vocal quality and the structure of the soft palate. Their argument 
did not provide good support for CRT as the assessment of jaw strength and the structure of 
the soft palate have been known to be poorly correlated with aspiration (McCullough et al., 
2001). The difference in terms of the optimal concentration between VFSS and FEES may be 
due to other limitations of the study: 1) the not equally experienced clinicians who conducted 
the FEES and VFSS and 2) the difference in patients’ age in VFSS and FEES. In addition, the 
findings reported in their study did not account for between-participant variability, diurnal 
variation and test-retest reliability which could be a concern when the test is used to track 
change in clinical settings.  
On the other hand, more recently, Guillén-Solà and colleagues (2015) conducted a 
prospective study to evaluate the sensitivity and specificity of citric acid CRT as a screening 
tool for SA in 134 stroke patients. The author reported the participants’ demographic 
information in great detail. CRT was conducted using the TB-SD method. Without 
mentioning whether a facemask or mouthpiece was used, the authors used an ultrasonic 
nebuliser (3 ml/min flow rate) in administering the citric acid. All patients were given a 
VFSS immediately after CRT and Penetration-Aspiration Scale (Rosenbek, Robbins, 
Roecker, Coyle, & Wood, 1996) was used as the VFSS outcome while CRT result was 
blinded from the rater. In their study, sensitivity and specificity of CRT in identifying SA was 




of SA in subacute stroke patients. Critically, this study used a different method than that used 
by Miles and colleagues (2013). They exposed patients to citric acids for 60 seconds instead 
of 15 seconds. Tachyphylaxis could take place on continuous citric acid exposure over 60 
seconds (Morice et al., 2007). A 1-minute exposure time has been shown to affect the 
reproducibility of the citric acid CRT (Morice et al., 1992). Another limitation of their study 
was the variability such as the test-retest reliability, between participants variability and 
diurnal variation were not taken into account. These variabilities might be the confounding 
factors that influence on the reproducibility of CRT results and may not reliably represent the 
true picture of patient’s cough sensitivity.   
 
3.4 Reproducibility of CRT 
Morice et al. (1992) have demonstrated short and long-term tachyphylaxis following 
prolonged exposure to citric acid over one minute or associated with repetitive CRTs. Their 
first experiment studied short-term tachyphylaxis using the TB-SD method (citric acid at 
0.68%) where participants were required to tidally breathe through a spacer for one minute 
while cough frequency was recorded within the same period (Collier & Fuller, 1984). All 
participant received two CRTs at a 1-week interval. The authors reported a marked reduction 
in cough frequency following one-minute of continuous citric acid exposure (mean cough 
frequency dropped from 4.9 to 0.5 coughs at the end of one minute for first CRT and 3.1 to 0 
for the second CRT). They reported a statistically significant difference within participant 
between tests, in which cough frequency for the first CRT was consistently higher than the 
second CRT when TB-SD method was used. In experiment two, the single breath dose-
response (SB-DR) method was utilised to evaluate long-term tachyphylaxis (Pounsford & 
Saunders, 1985). A series of CRTs were repeated within three hours using half-logarithmic 




CRT, participants were administered four one-second inhalations of each concentration with 
10-second inter-inhalations intervals.  They demonstrated a decline in cough frequency 
following four consecutive CRTs in 40 minutes and did not return to baseline even after 180 
minutes which was an indication of long-term tachyphylaxis. Tachyphylaxis was evident 
regardless of the methods of administrations used. Their findings suggest that short- and 
long-term tachyphylaxis might play an important role in affecting test-retest reliability. The 
reduction in cough frequency over time, either due to adaptation to the cough stimulant or 
familiarity of the testing procedure might lead to a nonreproducible finding; hence, a poor 
test-retest reliability.  
Dicpinigaitis (2003) attempted to define short- and long-term reproducibility of CRT 
using capsaicin. In studying short-term reproducibility, all 40 participants received two CRTs 
with a 14-day interval. In terms of long-term reproducibility, a separate group of 40 
participants underwent two CRTs at least six months between tests. CRTs were conducted 
using SB-DR method. Incremental doubling concentration of capsaicin aerosols ranging from 
0.98 – 1000 µmol/L (one inhalation each concentration) were administered via nebulisers 
with an output of 1.007 ml/min. Each inhalation was presented for 1.2 seconds at 1-minute 
inter-inhalation interval while cough frequency during 15 seconds immediately after each 
inhalation was recorded. The lowest concentration which triggered C2 and C5 would be 
treated as an individual’s cough threshold. Interestingly, they reported a remarkably good 
reproducibility between CRTs across participants. In terms of short-term reproducibility, they 
reported that C2 and C5 responses were reproducible within one doubling concentration in 
92% of total participants. For long-term reproducibility, they reported 100% and 79% 
reproducibility for C2 and C5 responses respectively, within one doubling concentration.  
Nejla and colleagues (2000) compared the TB-DR and SB-DR methods using capsaicin 




four patients with a pulmonary illness. All participants received two CRTs with a three-week 
inter-test interval. The TB-DR method required participants to tidally breathe from a 300 mL 
spacer for 15 seconds every one minute. Details about the number of trials administered per 
concentration and the used of facemask or mouthpiece were not reported. On the other hand, 
the SB-DR method required participants to exhale to residual capacity then inhale to total 
lung capacity. The capsaicin aerosols were administered using breath-activated dosimeter at 
1.6 seconds every one minute. For both methods, capsaicin aerosols ranging from 0.49-4000 
µmol/L were administered in incrementally doubling concentration manner. Cough frequency 
over the 15 seconds (TB-DR method) and one minute immediately after the aerosol was 
discharged (SB-DR method) were recorded and the lowest concentration which elicited C5 
response would be considered as an individual’s cough threshold. Using Pearson correlation 
analysis, they reported a good correlation between test one and test two using TB-DR method 
(r = 0.84) and SB-DR method (r = 0.76).  
Similar to that reported by Dicpinigaitis (2003), they concluded that capsaicin CRT has 
good reproducibility, regardless of the methodology used. However, their findings were 
conflicting with that reported by Morice et al. (1992). The main drawback from these studies 
is the lack of consistency in the type of irritants used, which could be a confounding factor 
influencing the test-retest reliability of CRT. Different studies used different irritants, thus 
comparison of the results across studies is impossible. Also, administration methodology 
such as the control of the inspiratory flow rate could be another factor that influences the 
reproducibility of CRT. For example, Dicpinigaitis (2003) limited the inspiratory flow rate to 
0.5 L/s by adding an inspiratory flow regulator valve to the setup which therefore optimised 
the reproducibility of inspiratory effort with each breath; hence gives rise to a reproducible 




To further validate the reproducibility of CRT, Wright et al. (2010) validated ERS 
standard citric acid CRT using the SB-DR method. In their study, they compared the 
conventional SB-DR method with a novel SB-DR method. The conventional SB-DR method 
involves four presentations of each half-logarithmic concentration (1, 3, 10, 30, 100, 300, 
1000 mmol/L). Each trial was presented for one second with a 30-second inter-trial interval. 
On the other hand, the novel method required participants to inhale only once of each 
doubling concentration (7.8, 15.6, 31.2, 62.5, 125, 250, 500 and 1000 mmol/L). All trials 
were presented for 1.2 seconds at 30 seconds interval.For both conventional and novel 
methods, production of cough during 15 seconds immediately after each inhalation was 
recorded and the lowest concentration which triggered C2 and C5 responses were treated as an 
individual’s cough threshold. CRTs were conducted at baseline, one, two, and four hours, as 
well as two weeks later. Both methodologies were refined through the use of a dosimeter to 
administer discrete doses within and across tests. They eliminated C5 from their analysis due 
to lack of reproducibility across participants. For novel CRT, the mean change from baseline 
was -1.57%, -3.14%, -2.08%, and 1.36% at 1, 2, 4 hours and 2 weeks later, respectively. 
Using the conventional method, the mean change from baseline at the same four time points 
were -9.79%, -10.70%, -11.69%, and -8.24%, respectively.  
The authors demonstrated a systematic trial effect (the mean threshold increased over 
time) for the conventional method with the effect lasting for two weeks. For the novel 
method, they observed a gradual increase in cough threshold at one and two hours which 
began to recover when the test was repeated at four hours after baseline, although it was still 
higher than baseline threshold. Unlike the conventional method, they observed a lower mean 
cough threshold two weeks after baseline measurement. Their findings revealed that the 
novel method has a higher intra- and inter-day reproducibility compared to conventional 




such as within- and between participants variability. Their findings further confirmed that 
administration protocol, dosing method and equipment used could impact the reproducibility 
of CRT. For example, administration method using one inhalation per concentration is more 
reproducible than four inhalations per concentration. The explanation for this could be that 
tachyphylaxis is more likely to take place when an individual receives four inhalations of 
each concentration more than once (Telaga et al., 1974). Their findings questioned the 
reproducibility of citric acid CRT using the TB-DR method, when the citric acid delivery 
time is as long as 15 seconds and there will be up to three exposures per concentration.  
 
3.5 Confounding factors affecting test-retest reliability  
3.5.1 Voluntary suppression of cough 
It has been known that cough can be voluntarily initiated and suppressed. Hutching et 
al. (1993) conducted a study to evaluate voluntary cough suppression using capsaicin CRT in 
28 healthy adults. For each CRT, five concentrations of capsaicin solutions (0, 10, 33.3, 100 
and 333 µmol/L) were administered using SB-DR method with one 1-second inhalation each 
concentration (1-minute inter-inhalations interval). All participants were administered two 
CRTs (natural cough test vs suppressed cough test) at five-minute inter-tests intervals in a 
random order. During the natural cough test, participants were told to relax and cough if they 
needed to. The suppressed cough test required participants to suppress their cough. Cough 
frequency within 30 seconds immediately after each inhalation was recorded. The authors 
compared pre- and post-CRT mean cough frequency of all concentrations for both conditions. 
For natural cough test, the mean cough frequency for the highest concentration was 2.94 ± 
0.34 (n=23) coughs; whilst for the suppressed cough test, it was 0.29 ± 0.18 (n=3) coughs. 
They proposed that there is some degree of voluntary suppression of cough in responding to 




natural and suppressed cough tests. For example, each of their participants received only one 
natural and suppressed cough test. It remains unknown if the higher SCT was due to 
voluntary suppression or variability of the test? 
Monroe et al. (2014), through a randomised control trial, established normative data of 
citric acid CRT using TB-DR method in 80 healthy individuals recruited from the community 
which being separated into two groups (group A and B). Group A participants (n=40) 
received citric acid ranging from 0.8 to 2.6 mol/L, with 0.2 mol/L increments; whereas, in 
Group B participants (n=40) received citric acid ranging from 0.1 to 1.2 mol/L with 0.1 
mol/L increments. The study protocols for both groups were similar to that by Miles et al. 
(2013b); the only difference was Monroe et al. (2014) evaluated natural cough threshold 
(NCT) and suppressed cough threshold (SCT). They reported a consistently higher threshold 
across groups when participants were instructed to suppress their cough. Their findings were 
in line with that by Hutching et al. (1993). Meanwhile, Eccles (2009) reported voluntarily 
suppression of natural cough until the reflexive cough pathway overrides the voluntary 
system; which is when a true reflexive cough is elicited. Their findings suggest that SCT is a 
preferred outcome measure that more closely reflects a true reflexive cough as part of the 
airway protection. A study involves a series of CRTs using SCT as the outcome measure is 
ideal for evaluating the variability of CRT.  
 
3.5.2 Diurnal variation 
A study by Pounsford & Saunders (1985) attempted to describe diurnal variation of 
citric acid CRT in 10 healthy adults. CRTs were conducted using SB-DR method at four 
different time points (two between 9am-12pm and two between 2-5pm); each CRT was 
conducted on a separate day. Order of the tests was randomised across participants. Citric 




of inhalations per concentration and inter-concentrations interval were reported. They 
revealed that the overall mean cough threshold for the afternoon session (0.23 [0.10] mol/L) 
was statistically higher than the morning session (0.15 [SD 0.02] mol/L). Using the SB-DR 
method, they confirmed the presence of diurnal variation on cough threshold among healthy 
adults.  
 
3.5.3 Order effect 
Interestingly, Perry and Huckabee (2017), adopting a similar TB-DR methodology used 
by Miles et al. (2013b) and Monroe et al. (2014) but different from that of Pounsford and 
Sauders (1985), and found no diurnal variation. The authors applied the same study design as 
that by Pounsford and Saunders (1985), except they controlled oral hygiene to limit the 
potential effect of oral bacterial on SCT. All participants were required to brush their teeth for 
two minutes prior to CRT. Citric acid aerosols ranging from 0.1-1.2 mol/L were administered 
in 0.1mol/L increments via a facemask. Participants were told to suppress their cough while 
breathing through their mouth normally. Each concentration was administered up to three 
times, 15 seconds each dose with placebo trials being randomly interspersed between 
incremental concentrations. Production of C2 over the 15 seconds period was considered as a 
positive result. The lowest concentration with at least two positive results out of three trials 
was considered as individual’s SCT. No diurnal variation was observed in their study. 
However, they discovered an order effect between first and the second CRTs - a higher mean 
SCT for the second CRT. It remains unknown if the inconsistent findings were due to 
different methodologies used in conducting CRT or learning effect across participants over 
time led to an increased SCT. However, this finding is not in line with the results found using 
capsaicin CRT as previously described. It would be interesting to evaluate the reliability of 




The test-retest reliability of citric acid CRT using TB-DR method is unknown. When 
there are data showing diurnal variation, order effect and technical factors can influence 
responses to CRT (Barber et al., 2005; Barros et al., 1990; Dicpinigaitis, 2003b, 2007; 
Dolovich, 1985; Khalid, 2012; Morice et al., 2007, 2001; Ryan et al., 1981). It is important to 
validate the reproducibility of citric acid CRT using TB-DR method, especially when it is a 
commonly used method in research and clinical settings. A sensitive and reproducible 
objective measure is crucial in establishing the association between cough sensitivity and 
pathology for clinical and research applications. This thesis will focus on the reliability of 
CRT using TB-DR method over five separate tests.		
 
3.6 Research aim 
To determine the variability and trial effect of citric acid CRTs on SCT in healthy 
individuals.  
 
3.7 Research questions  
1. What is the within-participant, test-retest variability?  










4.1 Screening/ exclusion criteria 
A screening was carried out through a face-to-face interview prior to recruitment; only 
healthy participants who met certain criteria were recruited. Individuals with current 
respiratory illness, history of drug abuse, past or current issue of swallowing difficulty, and/or 
current gastroesophageal reflux disease (GERD) (Harding & Richter, 1997; Irwin, 2007) 
were excluded from the study. Smokers or people with prolonged exposure to second-hand 
tobacco smoke were also excluded (Bergren, 2001; Dicpinigaitis, 2003a; Dicpinigaitis et al., 
2016; Lewis et al., 2007; Stravinskaite, Sitkauskiene, Dicpinigaitis, Babusyte, & Sakalauskas, 
2009). All participants using opioid-based medication such as painkillers (codeine, 
hydrocodone, Vicodin, OxyContin, Demerol, etc.), narcotics, or angiotensin-converting 
enzyme (ACE) inhibitors were not eligible in participating the study (Bolser, 2007; Morice et 
al., 2007; Morice, Marshall, Higgins, & Grattan, 1994). To avoid a ceiling effect, individual 
who did not cough at 1.6 mol/L were excluded from the present study.  
 
4.2 Participants and human ethics approval 
This study was approved by the Human Ethics Committee (HEC) of University of 
Canterbury (HEC 2016/82). A total of 16 healthy participants (15 females; mean age 30.25, 
range 20-48 years) were randomly recruited for this study and provided informed consent. 
Seven participants had previous experience with citric acid CRT. 
 
4.3 Oral hygiene 
As oral hygiene may influence cough reflex sensitivity in healthy individuals and 




without dentifrice (to avoid any contamination of chemical effect) prior to each CRT as oral 
hygiene control.  
 
4.4 CRT procedures 
Citric acid CRTs were carried out using the TB-DR protocol described by Monroe et 
al., (2014). The baseline test was administered at the same time of the day (11 am) for all 
participants and repeated five times with an inter-test interval between 30 and 90 minutes 
(mean 42 ± SD 12). During each test, participants were instructed to sit upright on a chair. 
Citric acid solutions were prepared in the university chemistry department by diluting citric 
acid powder in 0.9% NaCl. A placebo dose (0.9% NaCl) was presented at the beginning of 
each test to acclimatise participants to the procedure. A portable nebuliser (PulmoMate 
Compressor, Model 46501, DeVilbiss Healthcare LLC, Pennsylvania, USA) with a 
predetermined free-flow output of 8 L/min and restricted flow output of 6.6 L/min was used 
to administer citric acid aerosol. Citric acid, ranging from 0.1-1.6 mol/L, was administered in 
an ascending order of 0.1 mol/L increments with a 45-second inter-trial interval. Each 
concentration was administered up to three times for 15 seconds through a facemask. Placebo 
trials were randomly interspersed between incremental concentrations through the test to 
increase participant blinding. Participants were instructed to relax and breathe normally and 
to try to suppress their cough. Production of coughs during the 15-second delivery period was 
recorded. A test response was considered positive if a C2 response was generated on the 
administration of citric acid. The lowest concentration producing a positive result on 2/3 trials 
was deemed to be the participant’s SCT. The cut-off point of the test was either when SCT 
had been determined or when a participant did not cough at 1.6 mol/L (Miles, Zeng, 




4.5 Data analysis and model stability assessment  
The response variable in this study was participants’ SCT. To account for correlation in 
the data, due to each subject having five measurements of SCT, linear mixed effects model 
was performed using the lme4 package in R (version 1.0.143; Bates, Machler, Bolker, & 
Walker, 2014; R Development Core Team, 2013). Test number was treated as a continuous 
variable (one to five) and was entered in the model as a fixed effect. Intercept for participant 
was entered in the model as a random effect, this allowed each participant to have their own 
intercept randomly deviating from the mean intercept. Similarly to the random intercept, the 
random slope for participants allowed for the possibility that the effect of test on SCT can 
vary from participant to participant. The following parameters were estimated and reported 
from the model: 
1) Model fixed effects 
a. Model intercept: average SCT at baseline test across participants 
b. Model slope: average effect of test on SCT across participants 
2) Model random effects (variance estimates were derived for) 
a. Random intercept: Baseline SCT between participants 
b. Random slope: CRT effect between participants 
c. Residuals: SCT between tests within a participant  
i. The 95% prediction interval for the residuals:  the prediction 
interval provides a way to quantify the uncertainty of a single 
future observation from a population and can be used to derive a 
range where 95% of the SCT for a participant values will possibly 
fall in. 
Linear mixed models are valid under the following assumptions: 1) normality of 




intercepts) follow a normal distribution, and 3) residuals have constant variance. In order to 
investigate whether all the assumptions were met, visual inspection of the residuals and 
random effects using histograms, quantile-quantile plots (QQ-plot) and residuals-box-plot 
(Figure 1-4) were evaluated to detect deviations from normality and homoscedasticity  
The final model was as follow: 
lmer [SCT ~ 1 + CRT + (1 + CRT | Participant)] 
 
4.6 Model assumptions  
Visual inspection of the residuals (Figure 1) did not appear to be extremely skewed and 
no extreme outliers were found; however, a heavy-tailed Q-Q plot has been noted. Visual 
inspection of the random effects (Figure 2 & 3) appeared to be skewed and revealed notable 
deviations from normality.  
 
 






Figure 2. Histogram (left) and QQ-plot (right) of the random intercept 
 
Figure 3. Histogram (left) and QQ-plot (right) of the random slope 
 
A lack of homogeneity was observed when evaluating the variance of the residuals 
across participants. As it could be seen in Figure 4, some participants showed larger 
variability when compared to other participants (e.g: participant 3, 6, and 9). In addition to 
the visual inspections, a Levene’s test was employed to evaluate the equality of variance of 
the residuals across participants. Results from the Levene’s test revealed a statistically 





Figure 4. Box plot of the residuals for each participant across five CRTs	
 
4.7 Bootstrapping method 
To account for the non-normality of the residuals and random effects, a bootstrapping 
approach was preferred over data transformation as the transformation of the data would 
make the findings of the study difficult to be translated into clinical application. 
Bootstrapping confidence intervals (CIs) were calculated using the confint.merMod function 
in R. The Confint computes CIs on the parameters of a mixed model fit object. A thousand 
simulations were used to calculate the CI. 
4.7.1 Bootstrapping approach for residual prediction interval 
The bootstrapping approach to calculating the prediction interval of the residuals was 
carried out as the following: 
1.    The parametric model (e.g. the linear mixed effects model) was implemented and 




2.    Empirical prediction intervals with a lower margin 2.5th percentile and upper 
margin 97.5th percentiles for the residuals were calculated on every iteration.  
3.    Finally, an average of the lower and upper margin prediction interval was 





















The fixed effect results revealed that the mean SCT at baseline across participants 
(model intercept) was 0.29 mol/L, 95% bootstrapped CI [0.13, 0.45]. The effect of test on 
SCT was 0.003 mol/L, 95% bootstrapped CI [-0.02, 0.03]. For the random effects, the 
variability due to participants at baseline SCT was 0.33 mol/L, 95% bootstrapped CI [0.21, 
0.46]. The variability of the CRT effect between participants was 0.04 mol/L, 95% 
bootstrapped CI  [0.02,  0.06] while the variability for the residuals (SCT between tests 
within a participant) was 0.08 mol/L, 95% bootstrapped CI  [0.06,  0.09]. The 95% prediction 
interval for the residuals (variability within a participant) was [-0.14 mol/L,  0.16 mol/L].  
From a ratio of variance estimates of the random effects, the percentage of variability 
was derived for (Figure 5): 1) Baseline SCT between participants, 2) CRT effect between 
participants, and 3) SCT between tests within a participant. Figure 5 illustrates that between 
participants variability at baseline contributed the most to overall variance, followed by the 
variability between tests within a participant and the variability of the CRT effect between 






Figure 5. Pie chart showing the distribution of the percentage of variability of CRT 
 







6.1 Trial effect of repetitive CRTs 
This study is the first to evaluate the variability and trial effect of citirc acid CRT using 
TB-DR method. This study reveals no trial effect of repetitive CRTs with variability closes to 
zero (0.003 mol/L). The 95% CI includes zero effect reflects that there is no statistical 
significance trial effect of CRTs. Previous studies (Morice et al., 1992; Wright et al., 2010) 
have demonstrated a significant trial effect following repetitive exposures to citric acid; 
however, there is no distinct trial effect evident in this study. It may be due to different 
methodologies used in previous studies (e.g. TB-SD and SB-DR methods in Morice et al. 
[1992]; SB-DR method in Wright et al. [2010]). This finding suggests that citric acid CRT 
using TB-DR method may be a stable and effective tool for pre- and post-treatment measures.   
 
6.2 Variability of CRT 
This study discovered that variability due to baseline SCT between participants is the 
greatest which is about three dose levels (0.3 mol/L), followed by the within-participant 
variability which is about one dose level (0.1 mol/L) and the variability due to CRT effect 
between participants (almost zero). The baseline SCT appears to be quite variable across 
participants as shown by the participant random intercept (variability due to baseline SCT 
between participants), suggesting that different people behave differently towards CRT. For 
example, participant 1, 2, 4, 5, 7 and 10 had a much lower baseline SCT compared to that of 
participant 6 and 9 who had a much higher SCT (Figure 6, Appendix III). The reasonably 
high variability due to baseline SCT between participants suggests caution in establishing a 
normative threshold. It raises a concern when CRT using only single concentration is 
implemented clinically in detecting SA. The high variability due to baseline SCT between 




high SCT might be rated as failing the CRT when they did not cough at 0.6 mol/L (the 
concentration commonly used clinically). This might explain the poor sensitivity reported by 
Guillén-Solà and colleagues (2015) as participants in their study were tested using only single 
concentration without addressing the high variability in baseline SCT between participants. 
The box plot (Figure 4) and Levene’s test revealed that the variability for each 
participant was different with some participants showing a greater variability (e.g. 
participants 6 and 9) when compared to others with respect to repeated measures of CRT. 
This variability does not appear to be associated in a systematic way with the participant 
specific average SCT (e.g. a greater variability is present when the SCT is higher). However, 
the margins of error for the prediction intervals calculated in the bootstrapping technique may 
be too conservative for some participants while overestimates the others.  
Moreover, this study reveals fairly consistent (variability was within 0.1 mol/L) within-
participant measures. The 95% prediction interval for the residuals (variability within a 
participant) includes the value of zero effect which can be inferred that there is no statistical 
significance of within-participant variability. These findings reflect that citric acid CRT using 
TB-DR method may be useful for assessing change within a patient. When being assessed 
individually, an individual’s SCT is stable across tests using the TB-DR method. This study 
observes no learning effect for repeated CRTs within-participant. In other words, when a 
larger variability is observable in dysphagic patient population or research population, it may 
reflect a pathological condition or may be due to a therapeutic effect (treatment outcome 
measure).  
 
6.3 Possible contributing factors 
It is almost impossible to identify the contributing factors of these variabilities 




factors in contributing to the variability of CRT. The potential contributing factors to the 
between participants variation reported in this study might be the physiological and 
psychological contributions such as diurnal variation, individual personality, emotional state, 
level of attention, fatigues and etc. For example, participants with a competitive personality 
may use considerable effort to suppress their coughs whilst the others might give up and 
cough much earlier. As a result, participants with a competitive personality might have a 
higher SCT than the rest. This might be one of the contributing factors to the high variability 
at baseline SCT between participants evident in this study.  
The present study used the TB-DR protocol similar to previous studies (Monroe et al., 
2014; Perry & Huckabee, 2017). Without using an inspiratory flow regulatory valve, this 
method allows variability in individual’s breathing pattern, especially at high concentration 
(Khalid, 2012; Morice et al., 2001; Newman, Pitcairn, Hooper, & Knoch, 1994). It has been 
validated that inspiratory flow is in association with the inconsistent inhalation rate among 
participants through tidal breathing which could lead to various doses being inhaled 
(Dolovich, 1985; Morice et al., 2007; Ryan et al., 1981). The instruction to participants was 
to breathe normally; however, as the concentration increased, the researcher observed that 
some participants learned to manipulate their breathing pattern by using shallow tidal 
breathing, more frequent swallows or prolonged exhalation to minimise the amount of 
inhaled citric acids. As a result, participants who changed their breathing pattern tended to 
have a higher SCT than those who didn’t. The uncontrolled inspiratory flow may further 
explicit the impact of breathing method on the variation revealed in this study. It is highly 
recommended for future study to use an inspiratory flow regulatory valve to maintain a 
consistent inspiratory flow and a spirometry to monitor participants’ breathing pattern 




In general, this study adopts a simple, affordable and portable method which uses 
disposable jet nebulisers across tests and participants. There is evidence showing the high 
variability in nebuliser output across nebulisers (Dolovich, 1985; Hollie, Malone, Skufca, & 
Nelson, 1991; Ryan et al., 1981). The variability across nebulisers might contribute to the 
variability seen in this study; therefore, it is important for the future study to be consistent in 
using only one sterilisable nebuliser across tests and participants. The nebuliser needs to be 
calibrated regularly after multiple usages to ensure optimum performance and repeatable 
output.  
It has been shown that the nebulization method and reservoir volume, on the other 
hand, play a role in influencing the aerosol output. An increase in operating time changes the 
solution temperature that will affect the rate of evaporation. The greater the nebulization 
time, the lesser the overall output per minute, when there is no constant refilling of the 
reservoir (Dolovich, 1985). However, the nebulization time used in this study was short 
enough and consistent (15 seconds) across tests and participants; therefore, it is less likely to 
be a contributing factor to the variability observed in this study.  
 
6.4 Limitations 
In terms of the data analysis method, the SCT was introduced as a continuous variable. 
However, in reality, the SCT is not a continuous measure but an interval variable. This may 
be problematic as for some participants; their SCT might not fall in the interval value which 
leads to a less precise result. On the other hand, the box plot (Figure 4) and Levene’s test 
revealed a lack of homogeneity in the variance of the residuals across participants. The 
margin of error for the prediction interval calculated using the bootstrapping approach may 




Moreover, this study did not have enough data to generalise for gender and age. The 
findings reported in this study might not reflect the true population data but a specific group 
of the population. In addition, it was difficult to monitor an individual’s breathing pattern 
without having some measurement such as a spirometry. Participants were told to breathe 
normally through their mouth while suppressing their cough. However, they were not told to 
suppress swallowing. Some participants tended to swallow during the 15 seconds delivery 
period which could affect the amount of citric acid being inhaled. It has been known that 
respiration is ceased during swallowing (Matsuo & Palmer, 2009).  
 
6.5 Future directions 
6.5.1 Patient cohort 
Clinically, a simple and affordable protocol is preferred. It would be beneficial for 
future research to evaluate the reproducibility of citric acid CRT using the TB-SD method 
which is extensively used clinically in detecting SA among dysphagic patients. When the 
variability of CRT in the inpatient cohort is well-defined, clinicians will be more confident in 
interpreting the CRT result as it is more likely to reflect a true pathological condition or 
therapeutic effect (treatment outcome measure).  
 
6.5.2 A refined methodology as a research tool 
A well-controlled methodology using a minimum effective number of inhalations is 
vital to minimise trial effect while maintaining its sensitivity and reliability is vital when CRT 
is being used as a research tool. A more objective methodology would be ideal to improve the 
sensitivity of CRT and minimise rater error. It is strongly recommended for future studies to 
use an inspiratory flow regulatory valve to maintain a consistent inspiratory flow and 





This study is the first to define the variability of citric acid CRT using TB-DR method 
in healthy individuals. Outcome measures have to be sensitive and reliable in providing 
empirical evidence for dysphagia assessment and treatment methods.	These data suggest 
caution in establishing normative thresholds given the high percentage of variability for 
baseline SCT between participants. The fairly consistent within-participant measures suggest 
CRT may be useful for repeated measures in tracking change as treatment effect within an 
individual participant or patient. The variances reported in the present study suggest caution 
when interpreting the CRT results in both research and clinical purposes. If origins of 
variability can be identified and considered, the application of results from CRT can be 
improved. Despite these results, cannot be generalised to the pathologic population, perhaps, 
these findings can be used to compare the variances reported in patient groups while serving 
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PARTICIPANT INFORMATION SHEET 
Department of Communication Disorders 
Telephone: +64 3 364 2307 
Email: suhui.lim@pg.canterbury.ac.nz 
13th June 2016 
 
Trial Effect of Cough Reflex Test on Cough Reflex Sensitivity in Healthy 
Individuals 
Principal Investigator: Supervisor: Co-Supervisor: 
Su Hui Lim 
Master student 
Communication Disorders 
University of Canterbury 
suhui.lim@pg.canterbury.ac.nz 
(03) 364 2307 
Maggie-Lee Huckabee, PhD 
Professor 
Communication Disorders 
University of Canterbury 
maggie-
lee.huckabee@canterbury.ac.nz 
(03) 364 2042 
Phoebe Macrae, PhD 
Lecturer 
Communication Disorders 
University of Canterbury 
phoebe.macrae@canterbury.ac.nz 
(03) 364 2032 
 
 
I am an MSc student in Communication Disorders Department, performing a research project 
under the supervision of Prof Maggie-Lee Huckabee. You are invited to take part in a study 
determining the effect of repeatedly presented inhaled citric acid on the cough reflex 




and swallowing difficulty. Results from this study will aid us in developing rehabilitation 
approaches for people with absent cough reflex, like stroke patients.  
 
You can take part in this study if you are 18 years or older, and have no medical problems 
that may affect your respiratory and swallowing. If you choose to take part in this study, your 
involvement in this study will be to inhale citric acid which smells like an orange via a 
facemask on each test. It is a single visit which lasts for three hours and consists of five 
cough reflex tests with 30 minutes inter-test interval. Each test will take 15-20 minutes, you 
will be administered different dose of citric acids and instructed to breathe through your 
mouth comfortably while suppressing your cough. Each test will stop when the researcher has 
gotten your cough reflex threshold.  
 
Information about your cough reflex sensitivity will be stored on the computer and analysed 
at another time. The only data recorded will be the citric acid doses that represent your cough 
reflex sensitivity.  
 
The only benefit to you is that your participation contributes important information about 
cough reflex sensitivity shifting in healthy adults. There are no known risks in the 
performance of the tasks and application of the procedures. The only after test-effect is citric 
acid CRT might induce short-term tickling sensation in the throat in some participants but 
will resolve within 15-30 seconds. 
 
Participation is voluntary and you have the right to withdraw at any stage without penalty. 
You may ask for your raw data to be returned to you or destroyed at any point. If you 




starts on 3rd July 2017, it will become increasingly difficult to remove the influence of your 
data on the results. The results of the project may be published, but you may be assured of the 
complete confidentiality of data gathered in this investigation: your identity will not be made 
public without your prior consent. To ensure anonymity and confidentiality, no material 
which could personally identify you will be used in any reports on this study. Consent forms 
will be kept in a locked filing cabinet in the locked swallowing research laboratory or will be 
stored on password-protected laboratory computers. Research data will be stored for a period 
of 10 years after data collection is completed, at which time they will be destroyed. 
 
A thesis is a public document and will be available through the UC Library. You will be 
offered copies of the final manuscript of this study or a basic summary. Please indicate to the 
principal investigator on the consent form if you would like to receive a copy of the summary 
of results of the study. However, you should be aware that a significant delay may occur 
between completion of data collection and the final report. Alternatively, or in addition, you 
can choose to have the results of the study discussed with you personally by the principal 
investigator.  
 
You can contact the principal investigator if you require any further information about the 
study during work hours at (03) 364 2307 or through email: suhui.lim@pg.canterbury.ac.nz. 
She will be pleased to discuss any concerns you may have about participation in the study. 
 
This project has been reviewed and approved by the University of Canterbury Human Ethics 
Committee, and participants should address any complaints to The Chair, Human Ethics 






If you agree to participate in the study, you are asked to complete the consent form and return 
to the principal investigator.  
 
 
Su Hui, Lim 
Department of Communication Disorders 

















          
           
PARTICIPANT QUESTIONAIRE 
Department of Communication Disorders     
Telephone: +64 3 364 2307 
Email: suhui.lim@pg.canterbury.ac.nz 
3rd May 2016 
 





□ Do you have current respiratory infection or illness e.g. pneumonia, sore throat, chronic cough, 
running nose and etc.? 
If YES, please list out __________________________________________________________ 
 
□ Do you have history of drug abuse or current drug use (e.g. opioid-based medications – 
painkillers, codeine, hydrocodone, Vicodin, OxyContin, Demerol; narcotics; ACE inhibitors – 
hypertension medication; cough medication)?  






□ Do you have past or current issue of swallowing difficulty?  
If YES, please detail __________________________________________________________ 
 
□ Do you have current issue of gastroesophageal reflux disorder (GERD)? 
If YES, please detail __________________________________________________________ 
 
□ Do you have recent history of smoking or a current smoker? 

























          
           
PARTICIPANT CONSENT FORM 
Department of Communication Disorders     
Telephone: +64 3 364 2307 
Email: suhui.lim@pg.canterbury.ac.nz 
3rd May 2016 
 




Declaration by participant: 
I have read and I understand the Participant Information Sheet.   
□ I have been given a full explanation of this project and have had the opportunity to ask 
questions. 
□ I understand what is required of me if I agree to take part in the research. 
□ I understand that participation is voluntary and I may withdraw at any time without penalty.     
Withdrawal of participation will also include the withdrawal of any information I have provided 
should this remain practically achievable. 
□ I understand that any information or opinions I provide will be kept confidential to the 




reported results will not identify the participants. I understand that a thesis is a public document 
and will be available through the UC Library. 
□ I understand that all data collected for the study will be kept in locked and secure facilities 
and/or in password-protected electronic form and will be destroyed after 10 years.  
□ I understand the risks associated with taking part and how they will be managed. 
□ I understand that I am able to receive a report on the findings of the study by contacting the 
researcher at the conclusion of the project. 
□ I understand that I can contact the researcher [suhui.lim@pg.canterbury.ac.nz] or supervisor 
[maggie-lee.huckabee@canterbury.ac.nz] for further information. If I have any complaints, I 
can contact the Chair of the University of Canterbury Human Ethics Committee, Private Bag 
4800, Christchurch (human-ethics@canterbury.ac.nz).  
□ I would like a summary of the results of the project.  
□ I have been given a copy of the Participant Information Sheet and Consent Form to keep. 




Email address (for report of findings, if applicable):_________________________________ 
 
 
Su Hui, Lim 
Department of Communication Disorders 








          
           
PARTICIPANTS WANTED FOR STROKE RESEARCH STUDY 
 
Pilot Study 1: Trial Effect of Cough Reflex Test on Cough Reflex Sensitivity in 
Healthy Individuals 
 
We are looking for healthy men and women, 18 years and above, to participate in a study 
determining the trial effect of citric acid cough reflex test on the cough reflex sensitivity. 
Results from this study will aid us in developing rehabilitation approaches for people with 
absent cough reflex, like stroke patients. You may be eligible to participate if you do not 
have: 
 
1. Current issue of respiratory 
2. Current and past history of swallowing problem 
3. Current issue of gastroesophageal reflux disorder 
4. History of drugs abuse  
5. Prolonged exposure to tobacco smoke 
 
If you agree to participate in the study, you will have to inhale citric acid which smells like an 
orange via a facemask on a three hours single visit. You will be instructed to breathe through 




reflex tests with 30 minutes rest in between tests; each test will take 15-20 minutes. This 
study will be carried out at the Rose Centre in St George’s Hospital.  
 
If you are interested in participating, please contact: 
Su Hui, Lim 
Master Student 
University of Canterbury Rose Centre for Stroke Recovery and Research 
Private Bag 4737, 249 Papanui Rd, Christchurch 8140 







































































































































































































































































































































































































































































































































































































































































































































































































Appendix IV: R Code 
library(lme4)	
trial_effects_study	<-	read.csv("//file/UsersS$/shl68/Home/My	Documents/Trial	effect	
study.csv",	head=TRUE,	sep=",")	
str(trial_effects_study)	
	
#	changing	continuous	variable	to	ordinal	variable,	adding	'factor'	means	adding	another	
column	
trial_effects_study$Participants	<-as.factor(trial_effects_study$Participant)	
trial_effects_study$Test	<-	as.numeric(trial_effects_study$Test)	
str(trial_effects_study)	
	
library(lme4)	
mod1	<-	lmer(CRT~	1	+	Test	+	(1+Test|Participants),	data	=	trial_effects_study)	
	
library(lme4)	
smod2	<-	lmer(CRT~1+Test+(1+Test|Participants),	data	=	trial_effects_study)	
	
library(lattice)	
#checking	normality	and	variance	of	residuals	
r_int<-	ranef(mod1)$Participants$`(Intercept)`	
r_slope<-	ranef(mod1)$Participants$Test	
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plot(mod1)	
	
hist(residuals(mod1),	density=20,	breaks=20,	prob=TRUE,		
					xlab="Residuals",		
					main="Normal	curve	over	histogram	for	the	residuals")	
curve(dnorm(x,	mean=mean(residuals(mod1)),	sd=sd(residuals(mod1))),	
						col="darkblue",	lwd=2,	add=TRUE,	yaxt="n")	
qqnorm(residuals(mod1))	
qqline(residuals(mod1))	
	
hist(trial_effects_study$CRT,	density=20,	breaks=20,	prob=TRUE,		
					xlab="SCT",		
					main="histogram	for	the	outcome	variable	SCT")	
	
#checking	normality	of	intercepts	
qqnorm(r_int)	
qqline(r_int)	
hist(r_int,	density=20,	breaks=6,	prob=TRUE,		
					xlab="Random	intercept",		
					main="Normal	curve	over	histogram	for	the	random	intercept")	
curve(dnorm(x,	mean=mean(r_int),	sd=sd(r_int)),	
						col="darkblue",	lwd=2,	add=TRUE,	yaxt="n")	
	
#checking	normality	of	slopes	
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qqnorm(r_slope)	
qqline(r_slope)	
	
hist(r_slope,	density=20,	breaks=6,	prob=TRUE,		
					xlab="Random	slope",		
					main="Normal	curve	over	histogram	for	the	random	slope")	
curve(dnorm(x,	mean=mean(r_slope),	sd=sd(r_slope)),	
						col="darkblue",	lwd=2,	add=TRUE,	yaxt="n")	
#boxplot	(residuals	against	participant)	
ggplot(trial_effects_study,	aes(Participants,	residuals(mod1)))	+	geom_boxplot()	+	
		ggtitle("Box	plot	of	the	residuals	for	each	participant	accross	five	CRTs")+	
		labs(x="Participant",	y="Residuals")				
	
#boxplot	(SCT	against	participant)	
ggplot(trial_effects_study,	aes(Participants,	residuals(mod1)))	+	geom_boxplot()	+	
		ggtitle("Box	plot	of	participants’	SCT	across	five	CRTs")+	
		labs(x="Participant",	y="Suppressed	cough	threshold	(SCT	[mol/L])")	
	
#	estimated	model	coefficients	and	variance	components	
summary(mod1)	
coef(mod1)	
ranef(mod1)	
	
#	connfidence	intervals	for	test	&	participant	effects	to	make	inference	
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#	about	the	variability	of	CRT	within	participant	in	a	population	of	participants	
confint(mod1,	method="boot",	nsim=1000,	oldNames=FALSE)		
	
library(boot)	
#	confidence	interval	for	%	explained	variance	by	fixed	and	random	effects	
for	(i	in	1:1000)	{	
		###Create	the	model	
		mod1	<-	lmer(CRT~	1	+	Test	+	(1+Test|Participants),	data	=	trial_effects_study)	
	
		###Sample	80	points	with	replacement	from	the	residuals	(since	there	were	80	obs.)	
		#	we	need	replace	to	be	true	since	this	allows	for	reordering	the	residuals	but	also	to	use	
the	values	randomly,	
		#	so	that	we	can	repeat	some	values.	see	example	with	sample(1:10,	size	=	10);	
sample(1:10,	size	=	10,	replace=T)	
		Sample	<-	residuals(mod1)[sample(1:length(residuals(mod1)),	80,	replace=T)]	
			
		###Sort	the	sample	from	smallest	to	largest,	then	find	the	2.5th	and	97.5th	percentiles	
		sample_sorted<-sort(Sample)	
		lowerMOE<-
(sample_sorted[(0.025*(length(sample_sorted)))]+sample_sorted[(0.025*(length(sample_s
orted)))+1])/2	
		upperMOE<-
(sample_sorted[(0.975*(length(sample_sorted)))]+sample_sorted[(0.975*(length(sample_s
orted)))+1])/2	
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		###Put	the	results	in	the	data	frame,	adding	the	intercept	so	they	are	on	CRT	scale	
		MOE$LowerMOE[i]<-lowerMOE	
		MOE$UpperMOE[i]<-upperMOE	
}	
	
c(mean(MOE$LowerMOE),mean(MOE$UpperMOE))	
	
#ci	for	the	fixed	effects	
foo_f	<-	function(m){	
		i	=	j	#	1	for	intercept,	2	for	slope		
		return	(fixef(m)[i])		
}	
	
#	intercept	
j	=1	
bsm<-	bootMer(mod1,	foo_f,	1000)	
intercept_ci	<-	boot.ci(bsm,	type=	"perc")	
intercept_value	<-	fixef(mod1)[j]		
	
#slope	
j	=	2	
bsm<-	bootMer(mod1,	foo_f,	1000)	
slope_ci	<-	boot.ci(bsm,	type=	"perc")	
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slope_value	<-	fixef(mod1)[j]		
	
#	ci	for	random	effects	
foo_r	<-	function(m){	
		i	=	j	#	1	for	intercept,	2	for	slope,	4	for	residual	
		raneffects	<-	as.data.frame(VarCorr(mod1))[5]	
		return	(raneffects[j,1])		
}	
	
confint(mod1,	level=	0.95,	
								method	=	c("boot"),	
								nsim	=	1000,	
								boot.type	=	"perc",	oldNames	=	FALSE)	
	
#	intercept	
j	=1	
bsm<-	bootMer(mod1,	foo_r,	1000,	use.u=TRUE,	type="semiparametric")	
intercept_random_ci	<-	boot.ci(bsm,	type=	"perc")	
intercept_random_value	<-	as.data.frame(VarCorr(mod1))[j,5]	
	
#	slope	
j	=2	
bsm<-	bootMer(mod1,	foo_r,	1000)	
slope_random_ci	<-	boot.ci(bsm,	type=	"perc")	
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slope_random_value	<-	as.data.frame(VarCorr(mod1))[j,5]	
	
	
#	residuals	
j	=4	
bsm<-	bootMer(mod1,	foo_r,	1000)	
residuals_random_ci	<-	boot.ci(bsm,	type=	"perc")	
residuals_random_value	<-	as.data.frame(VarCorr(mod1))[j,5]	
	
	
	
	
	
